These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9199495)

  • 1. Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.
    Wagenknecht B; Gulbins E; Lang F; Dichgans J; Weller M
    FEBS Lett; 1997 Jun; 409(1):17-23. PubMed ID: 9199495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
    Wagenknecht B; Schulz JB; Gulbins E; Weller M
    Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of CD95 ligand and teniposide: no role of cleavable complex formation and enhanced CD95 expression.
    Winter S; Roth W; Dichgans J; Weller M
    Eur J Pharmacol; 1998 Jan; 341(2-3):323-8. PubMed ID: 9543255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis.
    La E; Kern JC; Atarod EB; Kehrer JP
    Toxicol Lett; 2003 Mar; 138(3):193-203. PubMed ID: 12565196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation.
    van Puijenbroek AA; Wissink S; van der Saag PT; Peppelenbosch MP
    Cytokine; 1999 Feb; 11(2):104-10. PubMed ID: 10089130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase metabolites as mediators of UTP-induced intracellular acidification in mouse RAW 264.7 macrophages.
    Lin WW; Chang SH; Wu ML
    Mol Pharmacol; 1998 Feb; 53(2):313-21. PubMed ID: 9463490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
    Roth W; Wagenknecht B; Grimmel C; Dichgans J; Weller M
    Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
    Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
    J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy primes malignant glioma cells for CD95 ligand-induced apoptosis up-stream of caspase 3 activation.
    Hueber A; Winter S; Weller M
    Eur J Pharmacol; 1998 Jul; 352(1):111-5. PubMed ID: 9718275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells.
    Roth W; Wagenknecht B; Dichgans J; Weller M
    J Neuroimmunol; 1998 Jul; 87(1-2):121-9. PubMed ID: 9670853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95 ligand: lethal weapon against malignant glioma?
    Weller M; Kleihues P; Dichgans J; Ohgaki H
    Brain Pathol; 1998 Apr; 8(2):285-93. PubMed ID: 9546287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.
    Schlapbach R; Fontana A
    Biochim Biophys Acta; 1997 Nov; 1359(2):174-80. PubMed ID: 9409814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
    Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
    J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoxygenase inhibitors induce rat hepatocyte apoptosis in primary culture].
    Korniĭchuk HM; Makohon NV; Lushnikova IV; Aleksieieva IM
    Ukr Biokhim Zh (1999); 2002; 74(1):125-7. PubMed ID: 12199093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
    Tani E; Kitagawa H; Ikemoto H; Matsumoto T
    FEBS Lett; 2001 Aug; 504(1-2):53-8. PubMed ID: 11522296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
    Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
    Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells.
    Biswal SS; Datta K; Shaw SD; Feng X; Robertson JD; Kehrer JP
    Toxicol Sci; 2000 Jan; 53(1):77-83. PubMed ID: 10653524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
    Roth W; Fontana A; Trepel M; Reed JC; Dichgans J; Weller M
    Cancer Immunol Immunother; 1997 Mar; 44(1):55-63. PubMed ID: 9111585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.